Malaria Genomics, Vaccine Development, and Microbiome

被引:2
|
作者
Su, Xinzhuan [1 ]
Stadler, Rachel V. [1 ]
Xu, Fangzheng [1 ]
Wu, Jian [1 ]
机构
[1] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA
来源
PATHOGENS | 2023年 / 12卷 / 08期
基金
美国国家卫生研究院;
关键词
Plasmodium; genetics; genotyping; genome diversity; antigen; PLASMODIUM-FALCIPARUM MALARIA; GENETIC DIVERSITY; DRUG-RESISTANCE; MONOCLONAL-ANTIBODIES; PROTECTIVE EFFICACY; ANTIGENIC VARIATION; SELECTIVE SWEEPS; GUT MICROBIOME; SIZE VARIATION; PFSPZ VACCINE;
D O I
10.3390/pathogens12081061
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent advances in malaria genetics and genomics have transformed many aspects of malaria research in areas of molecular evolution, epidemiology, transmission, host-parasite interaction, drug resistance, pathogenicity, and vaccine development. Here, in addition to introducing some background information on malaria parasite biology, parasite genetics/genomics, and genotyping methods, we discuss some applications of genetic and genomic approaches in vaccine development and in studying interactions with microbiota. Genetic and genomic data can be used to search for novel vaccine targets, design an effective vaccine strategy, identify protective antigens in a whole-organism vaccine, and evaluate the efficacy of a vaccine. Microbiota has been shown to influence disease outcomes and vaccine efficacy; studying the effects of microbiota in pathogenicity and immunity may provide information for disease control. Malaria genetics and genomics will continue to contribute greatly to many fields of malaria research.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Genomics and vaccine development
    Gay, C. G.
    Zuerner, R.
    Bannantine, J. P.
    Lillehoj, H. S.
    Zhu, J. J.
    Green, R.
    Pastoret, P-P.
    REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2007, 26 (01): : 49 - 67
  • [2] Paths to a malaria vaccine illuminated by parasite genomics
    Conway, David J.
    TRENDS IN GENETICS, 2015, 31 (02) : 97 - 107
  • [3] Development of a malaria vaccine
    Kwiatkowski, D
    Marsh, K
    LANCET, 1997, 350 (9092): : 1696 - 1701
  • [4] MALARIA VACCINE DEVELOPMENT
    MARTINEZ, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (01) : 63 - 63
  • [5] MALARIA VACCINE DEVELOPMENT
    JONES, TR
    HOFFMAN, SL
    CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (03) : 303 - 310
  • [6] DEVELOPMENT OF A MALARIA VACCINE
    COHEN, S
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1978, 71 (07) : 476 - 478
  • [7] Vaccine development against malaria
    Matuschewski, Kai
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (04) : 449 - 457
  • [8] DEVELOPMENT OF A SPOROZOITE MALARIA VACCINE
    NUSSENZWEIG, V
    NUSSENZWEIG, RS
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1986, 35 (04): : 678 - 688
  • [9] Rationale for the development of a malaria vaccine
    Nussenzweig, V
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1999, 6 (01) : 64 - 64
  • [10] ADVANCES IN THE DEVELOPMENT OF A MALARIA VACCINE
    PINK, JRL
    STURCHLER, D
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (49) : 1910 - 1914